743
Views
7
CrossRef citations to date
0
Altmetric
REVIEW

Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature

Pages 545-552 | Received 23 Dec 2022, Accepted 22 Feb 2023, Published online: 02 Mar 2023

References

  • Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455–461.
  • Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82:1045–1058.
  • Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6:18–20.
  • Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173:1546.
  • Kirsten N, Zander N, Augustin M. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population. Arch Dermatol Res. 2021;313:95–99.
  • Theut Riis P, Pedersen OB, Sigsgaard V, et al. Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study. Br J Dermatol. 2019;180:774–781.
  • Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35:191–194.
  • Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183:990–998.
  • Jemec GB, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol. 2015;73:5–7.
  • Jfri A, Nassim D, O’Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of Hidradenitis Suppurativa: a systematic review and meta-regression analysis. JAMA Dermatol. 2021;157:924–931.
  • Jfri A, Netchiporouk E, Raymond K, Litvinov IV, O’Brien E. Association of clinical severity scores with psychosocial impact in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2021;84:1712–1715.
  • Kjaersgaard Andersen R, Saunte SK, Jemec GBE, Saunte DM. Psoriasis as a comorbidity of hidradenitis suppurativa. Int J Dermatol. 2020;59:216–220.
  • Nikolakis G, Kaleta KP, Vaiopoulos AG, et al. Phenotypes and pathophysiology of syndromic Hidradenitis Suppurativa: different faces of the same disease? A systematic review. Dermatology. 2021;237:673–697.
  • Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010;2:9–16.
  • Jemec GB, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol. 2015;73(5 Suppl 1):S4–7.
  • Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013;133:97–103.
  • Ingvarsson G. Regional variation of hidradenitis suppurativa in the Norwegian Patient Registry during a 5-year period may describe professional awareness of the disease, not changes in prevalence. Br J Dermatol. 2017;176:274–275.
  • Sung S, Kimball AB. Counterpoint: analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;69:818–819.
  • Kirsten N, Petersen J, Hagenström K, Augustin M. Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol. 2020;34:174–179.
  • Kurokawa I, Hayashi N. Questionnaire surveillance of hidradenitis suppurativa in Japan. J Dermatol. 2015;42:747–756.
  • Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2018;32:1784–1790.
  • Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for Hidradenitis Suppurativa in the United States. JAMA Dermatol. 2017;153:760–764.
  • Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet. 1985;22:367–373.
  • Von Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142:947–953.
  • Brown TJ, Rosen T, Orengo IF. Hidradenitis suppurativa. South Med J. 1998;91:1107–1114.
  • Gao M, Wang PG, Cui Y, et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. 2006;126:1302–1306.
  • Mintoff D, Pace NP, Borg I. Interpreting the spectrum of gamma-secretase complex missense variation in the context of hidradenitis suppurativa – an in-silico study. Front Genet. 2022;13:962449.
  • Steiner K, Grayson LD. Hidradenitis suppurativa of the adult and its management. AMA Arch Derm. 1955;71:205–211.
  • Boer J, Jemec GBE. Mechanical forces and Hidradenitis Suppurativa. Exp Dermatol. 2021;30(2):212–215. doi:10.1111/exd.14234.
  • Zouboulis CC, Bechara FG, Fritz K, et al. S1 guideline for the treatment of hidradenitis suppurativa / acne inversa * (number ICD-10 L73.2). J Dtsch Dermatol Ges. 2012;10:S1–31.
  • Sayed CJ, Hsiao JL, Okun MMJO. Clinical epidemiology and management of hidradenitis suppurativa. Gynecology. 2021;137:731–735.
  • Boer J, Nazary M, Riis PT. The Role of Mechanical Stress in Hidradenitis Suppurativa. Dermatol Clin. 2016;34(1):37–43. doi:10.1016/j.det.2015.08.011.
  • Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982;118:101–102.
  • Benzecry V, Grancini A, Guanziroli E, et al. Hidradenitis suppurativa/acne inversa: a prospective bacteriological study and review of the literature. G Ital Dermatol Venereol. 2020;155(4):459–463. doi:10.23736/S0392-0488.18.05875-3
  • Bettoli V, Manfredini M, Massoli L, et al. Rates of antibiotic resistance/sensitivity in bacterial cultures of hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol. 2019;33(5):930–936. doi:10.1111/jdv.15332.
  • Revuz JE, Canoui-Poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59:596–601.
  • Freiman A, Bird G, Metelitsa AI, Barankin B, Lauzon G. Cutaneous effects of smoking. Surgery. 2004;8:415–423.
  • Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26(7):638–643.
  • Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg. 2003;56:451–461.
  • Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26:638–643.
  • Jansen T, Plewig G. What’s new in acne inversa (alias hidradenitis suppurativa)? J Eur Acad Dermatol Venereol. 2000;14:342–345.
  • Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther. 2004;17:50–54.
  • Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl. 2007;89:709–712.
  • Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl. 2007;89(7):709–712.
  • Cosman BC, O’Grady TC, Pekarske S. Verrucous carcinoma arising in hidradenitis suppurativa. Int J Colorectal Dis. 2000;15:342–346.
  • Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539–561.
  • Russ E, Castillo M. Lumbosacral epidural abscess due to hidradenitis suppurativa. AJR Am J Roentgenol. 2002;178:770–781.
  • Lapins J, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001;137:730–734.
  • Sharma YK, Chauhan S, Deo K. Follicular occlusion triad. J Dermatol Dermatol Surg. 2018;22:90–95.
  • Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010;2:9.
  • Giovanardi G, Chiricozzi A, Bianchi L, et al. Hidradenitis suppurativa associated with down syndrome Is characterized by early age at diagnosis. Dermatology. 2018;234:66–70.
  • Shalom G, Freud T, Harman-Boehm I, Polishchuk I, Cohen AD. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol. 2015;173:464–470.
  • Tzellos T, Zouboulis CC, Gulliver W, Cohen AD, Wolkenstein P, Jemec GB. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173:1142–1155.
  • Bui TL, Silva-Hirschberg C, Torres J, Armstrong AW. Hidradenitis suppurativa and diabetes mellitus: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;78:395–402.
  • Tiri H, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2018;79:514–519.
  • Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71:1144–1150.
  • Garg A, Papagermanos V, Midura M, Strunk A, Merson J. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States. J Am Acad Dermatol. 2018;79:495–500.
  • Noe MH, Mostaghimi A. The challenges of big data in dermatology. J Am Acad Dermatol. 2021;85:347–350.
  • Shahi V, Alikhan A, Vazquez BG, Weaver AL, Davis MD. Prevalence of hidradenitis suppurativa: a population-based study in Olmsted County, Minnesota. Dermatology. 2014;229:154–158.
  • Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007;56:621–623.
  • Kaaz K, Szepietowski JC, Matusiak Ł. Influence of itch and pain on sleep quality in patients with Hidradenitis Suppurativa. Acta Derm Venereol. 2018;98:757–761.
  • Riis PT, Vinding GR, Ring HC, Jemec GB. Disutility in patients with Hidradenitis Suppurativa: a Cross-sectional study using EuroQoL-5D. Acta Derm Venereol. 2016;96:222–226.
  • Kouris A, Platsidaki E, Christodoulou C, et al. Quality of life and psychosocial implications in patients with Hidradenitis Suppurativa. Dermatology. 2016;232:687–691.
  • Pavon Blanco A, Turner MA, Petrof G, Weinman J. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa? Br J Dermatol. 2019;180:338–345.
  • Janse IC, Deckers IE, van der Maten AD, et al. Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study. Br J Dermatol. 2017;176:1042–1047.
  • Sisic M, Tan J, Lafreniere KD. Hidradenitis Suppurativa, intimate partner violence, and sexual assault. J Cutan Med Surg. 2017;21:383–387.
  • Matusiak Ł, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010b;62:706–708.
  • Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GB. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170:884–890.
  • Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB. Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014;171:819–824.
  • Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2018;32(10):1784–1790.
  • Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V. Population-based clinical practice research datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178:917–924.
  • Hayama K, Fujita H, Hashimoto T, Terui T. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries. J Dermatol. 2020;47:743–748.
  • Liang YT, Yeh CJ, Huang JY, Wei JC. Epidemiology of hidradenitis suppurativa in Taiwan: a 14-year nationwide population-based study. J Dermatol. 2021;48:613–619.